Merck & Co Inc [MRK] stock is trading at $99.45, up 0.08%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The MRK shares have lost -0.47% over the last week, with a monthly amount glided 0.41%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Merck & Co Inc [NYSE: MRK] stock has seen the most recent analyst activity on December 20, 2024, when BMO Capital Markets downgraded its rating to a Market Perform and also revised its price target to $105 from $136. On December 04, 2024, upgrade upgraded it’s rating to Buy but maintained its price target of $130 on the stock. Wolfe Research started tracking the stock assigning a Peer Perform rating. Daiwa Securities downgraded its rating to a Neutral. Bernstein started tracking with a Mkt Perform rating for this stock on October 17, 2024, and assigned it a price target of $115. In a note dated March 11, 2024, Societe Generale downgraded an Sell rating on this stock but restated the target price of $104.
Merck & Co Inc [MRK] stock has fluctuated between $94.48 and $134.63 over the past year. Currently, Wall Street analysts expect the stock to reach $135.83 within the next 12 months. Merck & Co Inc [NYSE: MRK] shares were valued at $99.45 at the most recent close of the market. An investor can expect a potential return of 36.58% based on the average MRK price forecast.
Analyzing the MRK fundamentals
Merck & Co Inc [NYSE:MRK] reported sales of 62.89B for the trailing twelve months, which represents a growth of 4.42%. Gross Profit Margin for this corporation currently stands at 0.75% with Operating Profit Margin at 0.24%, Pretax Profit Margin comes in at 0.22%, and Net Profit Margin reading is 0.19%. To continue investigating profitability, this company’s Return on Assets is posted at 0.1, Equity is 0.29 and Total Capital is 0.17. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.86.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 98.95 points at the first support level, and at 98.45 for the second support level. However, for the 1st resistance point, the stock is sitting at 99.79, and for the 2nd resistance point, it is at 100.14.
Ratios To Look Out For
For context, Merck & Co Inc’s Current Ratio is 1.36. In addition, the Quick Ratio stands at 1.15 and the Cash Ratio stands at 0.49. Considering the valuation of this stock, the price to sales ratio is 4.00, the price to book ratio is 5.66 and price to earnings (TTM) ratio is 20.83.
Transactions by insiders
Recent insider trading involved Merck & Co., Inc., 10% Owner, that happened on Mar 11 ’24 when 21.4 million shares were purchased. EVP & CFO, Litchfield Caroline completed a deal on Feb 14 ’24 to sell 38291.0 shares. Meanwhile, Chairman, CEO & President Davis Robert M sold 0.15 million shares on Feb 13 ’24.
